In conclusion, CD25+/CD123+ positive coexpression is a reliable flow cytometry marker for prediction of the outcome of adult B-ALL patients and could be used as a novel parameter for risk stratification of adult B-ALL cases. Here, IL3RA is linked to precursor B-cell acute lymphoblastic leukemia.